Recent patents on drug delivery & formulation 2010-01-01

Properties and clinical development of a novel coating technology: the poly[bis(trifluoroethoxy)phosphazene].

Davide Capodanno, Corrado Tamburino

Index: Recent Pat. Drug Deliv. Formul. 4(1) , 18-22, (2010)

Full Text: HTML

Abstract

Ultrapure poly[bis(trifluoroethoxy)phosphazene] is a novel biocompatible, anti-inflammatory, antithrombogenic polymer which has the potential to cover stent devices without elution of a cell cycle inhibiting drug. The properties of polyphosphazene are likely to extend its use to a broad array of promising applications. This article reviews the features of the polymer and some recent patents related to use of poly[bis(trifluoroethoxy)phosphazene] in coating, its relevance as compared to other polymers, current evidence on pre-clinical and clinical performance, and future perspectives.

Related Compounds

Related Articles:

A new polymer concept for coating of vascular stents using PTFEP (poly(bis(trifluoroethoxy)phosphazene) to reduce thrombogenicity and late in-stent stenosis.

2005-04-01

[Invest. Radiol. 40(4) , 210-8, (2005)]

The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.

2007-05-01

[Invest. Radiol. 42(5) , 303-11, (2007)]

Radiation grafting of hydrophilic monomers onto poly[bis(trifluoroethoxy)phosphazene].

1994-09-01

[Biomaterials 15(11) , 937-43, (1994)]

Polyphosphazenes as biomaterials: surface modification of poly(bis(trifluoroethoxy)phosphazene) with polyethylene glycols.

1993-05-01

[Biomaterials 14(6) , 430-6, (1993)]

Arterial distribution characteristics of Embozene particles and comparison with other spherical embolic agents in the porcine acute embolization model.

2009-12-01

[J. Vasc. Interv. Radiol. 20(12) , 1597-607, (2009)]

More Articles...